
Marketing @Illumina | @UCSanDiego Alum
New York, NY
Joined January 2012
- Tweets665
- Following1.2K
- Followers523
- Likes1.7K
Fiona Nohilly retweeted
We’ve spent years pushing the limits of what short-read sequencing can do. Now, with our emerging constellation mapped read technology, we’re breaking new barriers and enabling the industry to uncover even deeper insights from the genome.
@GeneDx recently piloted constellation to evaluate its performance in the most challenging genomic regions. Early results illustrate its ability to rapidly identify hard-to-detect variants implicated in rare disease, like DMPK, SMN1, and mosaic aneuploidy.
Joe Devaney, Director of the Laboratory Innovation Team at GeneDx, said: “We’re continually looking to advance research and clinical genomics to drive the future of precision medicine and better health outcomes for all. The level of detail we can achieve with Constellation provides promising insight into some of the world’s most complex and difficult-to-diagnose diseases.”
Constellation delivers long-range genomic insights with a simplified, on-flow-cell library prep that removes manual steps — all within the workflows our customers know and trust.
📍GeneDx presented the results of their pilot today at #ASHG25. Read more here: bit.ly/4oaVLkh
Fiona Nohilly retweeted
2x300 on NovaSeq X #agbt25
Fiona Nohilly retweeted
These innovations are real—and customers are generating amazing insights with them TODAY. And even more is coming. For a deep dive into multiomics and informatics, don’t miss our #ASHG25 Industry Ed sessions tomorrow at 12pm and 3pm ET: bit.ly/4o7OHo1 (6/6)
Fiona Nohilly retweeted
At #ASHG25, KOL Bekim Sadikovic demonstrated the power of the new Illumina 5-base solution for accelerating resolution of rare disease cases. "Illumina's comprehensive 5-base technique—with the ability to use the combined genome sequencing and epigenetic data simultaneously—has the potential to change the way we look at functional genomics,” he said. (5/6)
Fiona Nohilly retweeted
🧬 Register to watch the session on-demand here: bit.ly/4o7OHo1 (7/7) #ASHG25
Fiona Nohilly retweeted
🧬 Early access user GeneDx reported accuracy, speed, and ease of use in their trial of Illumina’s up-and-coming constellation innovation. GeneDx’s Joe Devaney joined Steve on stage at #ASHG25 to discuss how it outperformed orthogonal methods in identifying difficult-to-map variants. (6/7)
Fiona Nohilly retweeted
🧬 A novel way to visualise and resolve even chromosome scale complex structural variants – the colocation plot enables mapping of breakpoints with each variant type, inversion, duplication etc, giving a unique pattern. #ASHG25 (5/7)
Fiona Nohilly retweeted
🧬 Constellation enables phasing of more full-length genes – fully phasing >97% of genes to allow better understanding of heritability and pathogenicity. #ASHG25 (4/7)
Fiona Nohilly retweeted
🧬 Previously, researchers had to choose between simplicity, scalability, and long-distance genomic insights. With constellation, you get simplicity (zero library prep), reliability of Illumina sequencing, accuracy in the most difficult parts of the genome, complex SVs, haplotype resolved paralogs, Mb scale phasing, and more. #ASHG25 (2/7)
Fiona Nohilly retweeted
🚨 New tech blog post from @illumina on constellation🌌 mapped read technology for long-range genomic insights for human #WGS from #NovaSeq X systems. illumina.com/science/genomic…
MiSeq i100 in the wild!!! check it out our booth at #ASHG24 🧬
10
400
very interesting and frightening. thankfully we've stopped doing treatments with cadaver derived growth hormones nature.com/articles/s41591-0… #Alzheimersresearch
1
208
Excited to be here in Ann Arbor attending the Midwest core lab directors mtg this week! #MWACD @illumina @illuminaLive – at Ann Arbor, MI




















